Whole-genome sequencing
Our proprietary approach uses the latest advances in whole-genome sequencing. This means that the entire genome is scanned - not only once, but twice, for increased accuracy.
Scientifically validated
Mable's approach is clinically tested with 700 patients in partnership with Illumina, the global leader in genomic sequencing.
Whole-genome sequencing
Mable's Medical Board includes world-renowned migraine experts from Harvard and University of California San Francisco.